{"id":2443,"date":"2016-05-15T07:26:38","date_gmt":"2016-05-15T07:26:38","guid":{"rendered":"https:\/\/kenes-exhibitions.com\/biomed20222016\/?page_id=2443"},"modified":"2022-04-24T11:42:11","modified_gmt":"2022-04-24T11:42:11","slug":"program-2","status":"publish","type":"page","link":"https:\/\/kenes-exhibitions.com\/biomed2022\/program-2\/","title":{"rendered":"Biomed Israel 2022 Agenda"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t

Biomed Israel 2022 PROGRAM<\/h2>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

TUESDAY, MAY 10<\/h2>\n\n\n\n\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t
09:00 - 09:15<\/td>Welcome by Conference Chairpersons:<\/b><\/td>\n<\/tr>\n
<\/td>Ruti Alon<\/a>, Founder and CEO, Medstrada<\/td>\n<\/tr>\n
<\/td>Ora Dar<\/a>, PhD, Senior Expert, Medical Sciences and Health Innovation<\/td>\n<\/tr>\n
<\/td>Nissim Darvish<\/a>, MD, PhD, Managing General Partner,\u00a0MeOHR Ventures<\/td>\n<\/tr>\n
09:15 - 09:30<\/td>Coffee Break<\/b><\/td>\n<\/tr>\n
<\/td>HALL A<\/b><\/td>\n<\/tr>\n
09:30 - 14:00<\/td>CELL, GENE AND NUCLEIC ACIDS THERAPIES - THE NEXT FRONTIER IN HUMAN HEALTH<\/b><\/td>\n<\/tr>\n
11:00 - 11:30<\/td>Coffee Break<\/b><\/td>\n<\/tr>\n
<\/td>Chairpersons: Erez Chimovits, Orbimed Partner, Private Equity, Rami Skaliter<\/a>, PhD, CEO, Cell Cure Neurosciences <\/td>\n<\/tr>\n
09:30 - 09:40<\/td>Opening Remarks: Erez Chimovits, Orbimed Partner, Private Equity <\/td>\n<\/tr>\n
09:40 - 10:00<\/td>Sumant Ramachandra, MD, PhD, President and CEO, ImmPACT Bio, \"Autologous CAR-T based therapies,\" \"ZOOM\"<\/td>\n<\/tr>\n
10:00 - 10:20<\/td>Chen Schor, President and CEO, Adicet Bio, \"Allogeneic CAR-T based therapies\"<\/td>\n<\/tr>\n
10:20-10:35
\n<\/td>		Noam Pilpel, PhD, CTO, Gilboa Therapeutics <\/a> <\/td>\n<\/tr>\n
10:35 - 10:55<\/td>Zhen Li, PhD, President and CEO, ADARx Pharmaceuticals, \"Oligonucleotide therapeutics\" <\/td>\n<\/tr>\n
11:30 - 11:45
\n<\/td>		Gili Hart, CEO, Splisense <\/a><\/td>\n<\/tr>\n
11:45 - 12:05<\/td>Adel Nada, MD, Co-founder and CEO, GentiBio, \"T-regs for curing autoimmunity\" <\/td>\n<\/tr>\n
12:05 - 12:25<\/td>David Baram, PhD, President and CEO, Emendo Biotherapeutics, \"Gene editing based therapies\" <\/td>\n<\/tr>\n
12:25 - 12:45
\n<\/td>		Michal Golan Mashiach, PhD, Founder and CEO, EdiTy Therapeutics <\/a><\/td>\n<\/tr>\n
12:45 - 13:00<\/td>Rami Skaliter<\/a>, PhD, CEO, Cell Cure Neurosciences, \"Embrionic stem cells therapies\" <\/td>\n<\/tr>\n
13:00 - 13:15
\n<\/td>		Yona Geffen, PhD, VP, R&D, Gamida Cell <\/a><\/td>\n<\/tr>\n
13:15 - 13:30<\/td>Noam Diamant, PhD, Co-founder and CEO, Noga Therapeutics <\/a><\/td>\n<\/tr>\n
13:30 - 13:45<\/td>Adi Elkeles, PhD, Founder and CEO, Trobix Bio <\/a><\/td>\n<\/tr>\n
13:45 - 14:00<\/td>Prof. Dror Mevorach, MD, CSO, Enlivex Therapeutics, \"Allocetra-OTS: High synergistic effectiveness against solid tumor with immune check point inhibitors or CAR T.\"<\/td>\n<\/tr>\n
14:00 - 15:00<\/td>Lunch Break<\/b><\/td>\n<\/tr>\n
<\/td>HALL B<\/b><\/td>\n<\/tr>\n
09:30 - 14:00<\/td>MEDICAL DEVICE - BREAKTHROUGH TECHNOLOGIES<\/b><\/td>\n<\/tr>\n
11:00 - 11:30<\/td>Coffee Break<\/b><\/td>\n<\/tr>\n
<\/td>Chairperson: Eyal Lifschitz, Co-founder and General Managing Partner, Peregrine Ventures
\n<\/td>\n<\/tr>\n
09:30 - 09:45<\/td>David Rigler, VP Clinical Research and Regulatory Affairs, Nano Retina <\/a><\/td>\n<\/tr>\n
09:45 - 10:00<\/td>Ronen Eckhouse, Co-founder and CEO, Rapid Medical <\/a><\/td>\n<\/tr>\n
10:00 - 10:15<\/td>Amir Danino, Founder and CEO, Innoventric <\/a> <\/td>\n<\/tr>\n
10:15 - 10:30<\/td>Shlomit Chappel-Ram, PhD, VP, R&D, Digma Medical <\/a> <\/td>\n<\/tr>\n
10:30 - 10:45<\/td>Yotam Drechsler, CEO and Co-founder, BrainQ Technologies <\/a> <\/td>\n<\/tr>\n
10:45 - 11:05<\/td>Daniel Goldstein, PhD, Advocate and Patent Attorney, Sanford T. Colb & Co., \"Ecosystems and homeostasis: A law and technology look at the field of medical devices\"<\/td>\n<\/tr>\n
11:30 - 11:45<\/td>Ronen Segal, CTO, Alpha Tau Medical <\/a><\/td>\n<\/tr>\n
11:45 - 12:00<\/td>Avner Geva, Founder and CEO, Vensica Therapeutics <\/a><\/td>\n<\/tr>\n
12:00 - 12:15<\/td>Idan Geva, CEO, <\/td>\n<\/tr>\n
12:15 - 12:35<\/td>Joseph (Joe) Smith, MD, PhD, CSO, Becton Dickinson, \"BD - Innovation at Scale\"<\/td>\n<\/tr>\n
12:35 - 12:50<\/td>Benny Dilmoney, CEO, Magneto Thrombectomy Solutions <\/a><\/td>\n<\/tr>\n
12:50 - 13:05<\/td>Gilad Marom, CEO, Restore Medical <\/a><\/td>\n<\/tr>\n
13:05 - 13:20<\/td>Dvir Cohen<\/a>, CEO and President, Memic Innovative Surgery<\/td>\n<\/tr>\n
13:20 - 13:30<\/td>Closing Remarks: Eyal Lifschitz, Co-founder and General Managing Partner, Peregrine Ventures <\/td>\n<\/tr>\n
13:30 - 13:50<\/td>Sandra Morgan, Board Director and Advisor, Healthcare, Pharmaceutical, and Technology, \"MedTech 2032: The Future\" <\/td>\n<\/tr>\n
14:00 - 15:00<\/td>Lunch Break<\/b><\/td>\n<\/tr>\n
<\/td>HALL C<\/b><\/td>\n<\/tr>\n
09:30-14:00<\/td>BIO FOOD - NEW ERA OF FOOD TECHNOLOGIES; ITS IMPACT ON NUTRITION AND HEALTH<\/b><\/td>\n<\/tr>\n
11:00 - 11:30<\/td>Coffee Break<\/b><\/td>\n<\/tr>\n
<\/td>Chairperson: Tammy Meiron, PhD, CTO, Fresh Start FoodTech Incubator<\/td>\n<\/tr>\n
09:30 - 09:55<\/td>Valerio Nanninni, General Manager, Novozymes Advanced Proteins Solutions, \"The food industry perspective and the adaptation of bio-tech technologies\" <\/td>\n<\/tr>\n
09:55 - 10:20<\/td>Matthew Robin, CEO, Mifloma Group-at Migros Industries, \"The perspective of a leading FoodTech company, entering the Bio Food arena\"<\/td>\n<\/tr>\n
10:20 - 10:45<\/td>Prof. Yaakov Nahmais, PhD, Founder and President, Future Meat Technologies, \"The evolution of a Bio Food Company in the eye of an academic researcher\" <\/td>\n<\/tr>\n
10:45 - 11:00<\/td>Ilan Samish, Phd, Founder and CEO, Amai Proteins <\/a> <\/td>\n<\/tr>\n
11:30 - 11:55<\/td>Prof. Eldad Tzahor, PhD, Co-founder and scientific advisor, Profuse Tech, \"Bioconversion - the Case Study of Profuse\" <\/td>\n<\/tr>\n
11:55 - 12:20<\/td>Miriam Guggenheim, Co-chair, Covington\u2019s Israel International Initiative, \"Regulatory barriers and challenges in adaptation of bio-tech platforms into foods\"<\/td>\n<\/tr>\n
12:20 - 12:35<\/td>Tal Lutzky, Co-founder and CEO, Pigmentum <\/a> <\/td>\n<\/tr>\n
12:35 - 12:50<\/td>Neta Lavon, PhD, CTO, Aleph Farm <\/a><\/td>\n<\/tr>\n
12:50 - 13:05<\/td>Orna Harel, PhD, Co-founder and CEO, Sea 2 Cell <\/a><\/td>\n<\/tr>\n
13:05 - 13:20<\/td>Tsipi Shoham, PhD, Co-founder and CEO, GreenOnyx <\/a> <\/td>\n<\/tr>\n
13:20 - 13:35<\/td>Iftach Nachman, PhD, Co-founder and Scientific Advisor, Forsea <\/a><\/td>\n<\/tr>\n
13:35 - 13:50<\/td>Fabian Trumper, Co-founder and CEO, Bountica <\/a> <\/td>\n<\/tr>\n
13:50 - 14:05<\/td>Prof. Nurit Argov-Argaman, PhD, CTO, Wilk <\/a><\/td>\n<\/tr>\n
14:00 - 15:00<\/td>Lunch Break<\/b><\/td>\n<\/tr>\n
<\/td>PLENARY SESSION <\/b><\/td>\n<\/tr>\n
15:15 - 15:45<\/td>Mikael Dolsten, MD, PhD, Chief Scientific Officer and President, \"ZOOM\"
\nFireside Chat with: Gil Bar-Nahum, PhD, Managing Director, Jefferies International, UK
\n<\/td>\n<\/tr>\n
15:45 - 16:15<\/td>Robert Cohen<\/a>, MS, President, Digital, Robotics, and Enabling Technology, Stryker, \"Orthopedic industry and clinical insights - AI and predictive analytics,\" \"ZOOM\"<\/td>\n<\/tr>\n
16:15 - 16:45<\/td>Gil Bar-Nahum<\/a>, PhD, Managing Director, Jefferies International, UK, \"The State of Life Sciences Industry, Today and Tomorrow\"<\/td>\n<\/tr>\n
16:45 - 17:15<\/td>Sandra Morgan, Board Director and Advisor, Healthcare, Pharmaceutical, and Technology, \"Trials and Tribulations on the Riad to Marketing and Selling your Products to the USA Healthcare System\" <\/td>\n<\/tr>\n
17:30 - 20:00<\/td>Gala Event<\/b><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

WEDNESDAY, MAY 11<\/h2>\n\n\n\n\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t
<\/td>HALL A<\/b><\/td>\n<\/tr>\n
09:30 - 11:30<\/td>ACADEMIA - WHERE IS IT TAKING US? SCIENCE AND TECHNOLOGY - PREDICTION AND ANTICIPATION<\/b><\/td>\n<\/tr>\n
11:00 - 11:30<\/td>Coffee Break<\/b><\/td>\n<\/tr>\n
<\/td>Chairperson: Keren Primor Cohen, CEO, Ramot Tel Aviv University<\/td>\n<\/tr>\n
09:30 - 09:35<\/td>Opening Remarks: Keren Primor Cohen, CEO, Ramot Tel Aviv University<\/td>\n<\/tr>\n
09:35 - 09:42<\/td>Tamar Harel Adar, PhD, VP R&D, Matricelf <\/a> <\/td>\n<\/tr>\n
09:42 - 09:49<\/td>Yan Ostrovski, PhD, Co-founder and CEO, Neshima Medical <\/a><\/td>\n<\/tr>\n
09:49 - 09:55<\/td>Pini Tsukerman, PhD, Co-founder and CEO, \n> NectinTX Therapeutics <\/a><\/td>\n<\/tr>\n
09:55 - 10:02<\/td>Prof. Ehud Gazit, PhD, Professor, Blavatnik Center for Drug Discovery<\/td>\n<\/tr>\n
10:02 - 10:09<\/td>Ophir Herbst, CEO, Sequentify <\/a> <\/td>\n<\/tr>\n
10:09 - 10:14<\/td>Prof. Ronit Satchi-Fainaro, PhD, Head and Director, Cancer Biology Research Center, Tel Aviv University <\/a> <\/td>\n<\/tr>\n
10:14 - 10:21<\/td>David Gabay, Co-founder, Chairman and CEO, Madrigal Mental Care <\/a> <\/td>\n<\/tr>\n
10:21 - 11:35<\/td>Panel<\/b> \"Building a commercialization marketplace - no more \"academic ivory towers\"\"<\/td>\n<\/tr>\n
10:21 - 10:36<\/td>Moderator: Keren Primor Cohen, CEO, Ramot Tel Aviv University<\/td>\n<\/tr>\n
10:36 - 11:35<\/td>Yuval Cabilly, PhD, Co-founder and Managing Partner, Israel Biotech Fund<\/td>\n<\/tr>\n
10:36 - 11:35<\/td>Joel Bar-El, Founder and Executive Chairman, Unicorn Trax<\/td>\n<\/tr>\n
10:36 - 11:35<\/td>Prof. Jacob (Koby) Rubinstein, PhD, VP, R&D and Chairman, T3 - Technion Technology <\/td>\n<\/tr>\n
10:36 - 11:35<\/td>Aviv Zeevi, PhD, VP, Head of Division, Israel Innovation Authority<\/td>\n<\/tr>\n
10:36 - 11:35<\/td>Lior Shahory, General Partner, Peregrine Ventures<\/td>\n<\/tr>\n
<\/td>HALL A<\/b><\/td>\n<\/tr>\n
12:00-14:00<\/td>BIO CONVERGENCE - ENGINEERING AND BIOTECHNOLOGY COMBINED, EXPANDING TO OTHER VERTICALS<\/b><\/td>\n<\/tr>\n
<\/td>Chairperson: Efi Cohen Arazi<\/a>, CEO, TanoMed<\/td>\n<\/tr>\n
12:00 - 12:05<\/td>Opening Remarks: Efi Cohen Arazi<\/a>, CEO, TanoMed<\/td>\n<\/tr>\n
12:05 - 12:10<\/td>Dror Bin, CEO, Israel Innovation Authority<\/td>\n<\/tr>\n
12:10 - 12:22<\/td>Daniel N. Weiss, MD, Medical Director, Enopace Biomedical <\/a><\/td>\n<\/tr>\n
12:22 - 12:34<\/td>Aryeh Batt, CEO and Co-founder, Precise Bio <\/a><\/td>\n<\/tr>\n
12:34 - 12:46<\/td>Ofri Vaisman, COO and General Manager, BlueWind Medical <\/a><\/td>\n<\/tr>\n
12:46 - 12:58<\/td>Iris Alroy, PhD, CSO and CO-founder, Anima Biotech <\/td>\n<\/tr>\n
12:58 - 13:10<\/td>Alon Meir, PhD, CSO, Seevix Material Sciences <\/a><\/td>\n<\/tr>\n
13:10 - 13:22<\/td>Yuval Mandelbaum, CEO, Discure Technologies <\/td>\n<\/tr>\n
13:22 - 14:00<\/td>Panel<\/b> \"Bio Convergence talent: the multidisciplinary opportunity and challenge\u201d<\/td>\n<\/tr>\n
<\/td>Moderator: Daphna Murvitz, Ceo and Co-founder, 8400-The Health Network <\/td>\n<\/tr>\n
<\/td>Tzvika Hartman, SVP Computational, Biolojic Design<\/td>\n<\/tr>\n
<\/td>Aryeh Batt, CEO and Co-founder, Precise Bio<\/td>\n<\/tr>\n
<\/td>Prof. Ronit Satchi-Fainaro, PhD, Head and Director, Cancer Biology Research Center, Tel Aviv University, <\/td>\n<\/tr>\n
<\/td>Merav Bassan, PhD, CDO, BiomX<\/td>\n<\/tr>\n
14:00-15:00<\/td>Lunch Break<\/b><\/td>\n<\/tr>\n
<\/td>HALL B<\/b><\/td>\n<\/tr>\n
09:30 - 14:00<\/td>AI AND MACHINE LEARNING - TRANSFORMING TREATMENT, DRUG DISCOVERY AND DEVELOPMENT<\/b><\/td>\n<\/tr>\n
11:00 - 11:30<\/td>Coffee Break<\/b><\/td>\n<\/tr>\n
<\/td>Chairperson: Yair Benita, PhD, CTO, AION Labs<\/td>\n<\/tr>\n
09:30 - 09:45<\/td>Shai Shen-Orr, PhD, Co-founder and Chief Scientist, CytoReason <\/a><\/td>\n<\/tr>\n
09:45 - 10:00<\/td>Micah Pearlman, CEO, Biolojic <\/a> <\/td>\n<\/tr>\n
10:00 - 10:15<\/td>Ranit Aharonov, PhD, CTO, Pangea Biomed <\/a><\/td>\n<\/tr>\n
10:15 - 10:30<\/td>Anat Binur, PhD, Co-founder and CEO, UKKO<\/td>\n<\/tr>\n
10:30 - 10:45<\/td>Noam Solomon, PhD, CEO, Immunai <\/a> <\/td>\n<\/tr>\n
10:45 - 11:00<\/td>Isaac Bentwich, MD, Founder and CEO, Quris Technologies <\/a> <\/td>\n<\/tr>\n
11:30 - 11:45<\/td>Nadav Askari, PhD, CTO, Genetika+ <\/a> <\/td>\n<\/tr>\n
11:45 - 12:15<\/td>James Weatherall, PhD, VP, Data Science and Artificial Intelligence, R&D, AztrtaZeneca, \"Pushing the boundaries of science through Data Science and Artificial Intelligence,\" \"ZOOM\"<\/td>\n<\/tr>\n
12:15 - 12:45<\/td>Eran Harary, MD, Global Head, Specialty R&D, Teva Pharmaceuticals, \"The innovative productivity crisis in the pharmaceutical R&D - Challenges and Potential AI and ML Solutions\" <\/td>\n<\/tr>\n
12:45 - 13:15<\/td>Jason Johnson, PhD, Chief Data and Analytics Officer, SVP, Dana Farber Cancer Institute, \"It's about the Data: strategies for enabling and productionizing Al and Machine learning,\" \"ZOOM\"<\/td>\n<\/tr>\n
13:15 - 13:45<\/td>David Berry, MD, PhD, Founder, CEO and General Partner at Flagship Pioneering, Valo Health, \"Accelerating drug discovery and development,\" \"ZOOM\"<\/td>\n<\/tr>\n
13:45 - 14:00<\/td>Yair Benita, PhD, CTO, AION Labs <\/td>\n<\/tr>\n
14:00 - 15:00<\/td>Lunch Break<\/b><\/td>\n<\/tr>\n
<\/td>HALL C<\/b><\/td>\n<\/tr>\n
09:30 - 14:00<\/td>CURRENT AND FUTURE ROLE OF ROBOTICS IN THE MEDICAL FIELD<\/b><\/td>\n<\/tr>\n
11:00 - 11:30<\/td>Coffee Break<\/b><\/td>\n<\/tr>\n
<\/td>Chairperson: Dvir Cohen<\/a>, CEO and President, Memic Innovative Surgery<\/td>\n<\/tr>\n
09:30 - 09:35<\/td>Opening Remarks: Dvir Cohen, CEO and President, Memic Innovative Surgery <\/td>\n<\/tr>\n
09:35 - 10:00<\/td>Prof. Alexandre Mottrie, PhD, MD, CEO, Orsi Academy, \"Past, present and future of surgical robotics, \"ZOOM\"<\/td>\n<\/tr>\n
10:00 - 10:25<\/td>Gus Castello, Cognos-Lux Consulting LLC, \"Building operational excellence in surgical robotics\" <\/td>\n<\/tr>\n
10:25 - 10:50<\/td>Michael Kasser, PhD, Director of Regulatory Sciences, Hogan Lovells, <\/td>\n<\/tr>\n
10:50 - 11:05<\/td>Seong Ryong Kang, PhD, CEO, Korea-Israel industrial R&D foundation (KORIL), \"ZOOM\" with Hadar Zax, Program Manager at Israel Asia-Pacific Division, \"Israel and S. Korea-the lighthouse program\"
\n<\/td>\n<\/tr>\n
11:30 - 11:45<\/td>Michael Conditt, PhD, SVP, Strategic Marketing and Clinical Development, Memic Innovative Surgery<\/td>\n<\/tr>\n
11:45 - 12:00<\/td>Tami Frenkel, PhD, Co-founder and CEO, Human Xtensions <\/a> <\/td>\n<\/tr>\n
12:00 - 12:15<\/td>Chen Levin, CEO, Xact Robotics <\/a> <\/td>\n<\/tr>\n
12:15 - 12:30<\/td>Noam Hassidov, CEO, Tamar Robotics <\/a> <\/td>\n<\/tr>\n
12:30 - 12:45<\/td>Gaddi Menahem, VP, Head of Intuitive Israel, Intuitive <\/a> <\/td>\n<\/tr>\n
12:45 - 13:00<\/td>Yosi Weitzman, Founder, COO\/CTO, GM Israeli Site, Carevature Medical <\/a><\/td>\n<\/tr>\n
13:00 - 13:15<\/td>Eyal Morag, MD, CMO, Microbot Medical <\/a><\/td>\n<\/tr>\n
13:15 - 13:30<\/td>Lawrence Obstfeld, CEO, Image Navigation <\/a> <\/td>\n<\/tr>\n
13:30 - 13:55<\/td>Maurice R. Ferre, MD, Former co-founder and CEO, Mako Surgical, \"Building a robotic company: lessons learned,\" \"ZOOM\" <\/td>\n<\/tr>\n
13:55 - 14:00<\/td>Closing Remarks: Dvir Cohen, CEO and President, Memic Innovative Surgery <\/td>\n<\/tr>\n
14:00 - 15:00<\/td>Lunch Break<\/b><\/td>\n<\/tr>\n
<\/td>PLENARY SESSION<\/b><\/td>\n<\/tr>\n
15:15 - 15:35<\/td>Dror Bin, CEO, Israel Innovation Authority<\/td>\n<\/tr>\n
15:35 - 16:05<\/td>Janneke Van Der Kamp, Head Region Europe, Novartis, \"Bending the Curve of Life:how partnerships can redefine cardiovascular disease care\"<\/td>\n<\/tr>\n
16:05 - 16:45<\/td>Robert S. Langer, DSc, Institute Professor, MIT Department of Chemical Engineering, \"ZOOM\"
\nFireside Chat with: Amy W. Schulman, Managing Partner, Polaris Partners, \"ZOOM\" <\/td>\n<\/tr>\n
16:45 - 17:15<\/td>John D. Halamka, MD, MS, President, Mayo Clinic Platform, \"ZOOM\"<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

THURSDAY, MAY 12<\/h2>\n\n\n\n\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t
<\/td>HALL A<\/b><\/td>\n<\/tr>\n
09:30-14:00<\/td>TRANSFORMATIVE PRECISION CANCER DIAGNOSTICS AND THERAPIES<\/b><\/td>\n<\/tr>\n
11:00 - 11:30<\/td>Coffee Break<\/b><\/td>\n<\/tr>\n
<\/td>Chairperson: Ofer Sharon<\/a>, MD, CEO, OncoHost<\/td>\n<\/tr>\n
09:30 - 09:35<\/td>Opening Remarks: Ofer Sharon<\/a>, MD, CEO, OncoHost, \"Precision medicine challenges and opportunities\" <\/td>\n<\/tr>\n
09:35 - 09:45<\/td>Prof. Dror Harats, MD, CEO, VBL Therapeutics, \"New Treatment strategies for Solid Tumors: major Leaps, but still work to be done\" <\/td>\n<\/tr>\n
09:45 - 10:00<\/td>Prof. Dror Harats, MD, CEO, VBL Therapeutics <\/td>\n<\/tr>\n
10:00 - 10:15
\n<\/td>		Roni Mamluk, PhD, Founder and CEO, Ayala Pharma <\/a><\/td>\n<\/tr>\n
10:15 - 10:30<\/td>Isaac Israel, CEO, Purple Biotech <\/a> <\/td>\n<\/tr>\n
10:30 - 10:45<\/td>Ilana Mandel, PhD, VP, R&D, Biond Biologics <\/a> <\/td>\n<\/tr>\n
10:45 - 11:00<\/td>Eran Ophir, PhD, VP Research and Drug Discovery, Compugen <\/a><\/td>\n<\/tr>\n
11:30 - 12:00<\/td>Reddy Prasanth, MD, SVP, Global Enterprise Oncology Head, Covance\/Labcorp Drug Development<\/td>\n<\/tr>\n
12:00 - 12:15<\/td>Ronen Eavri, PhD, Co-founder and CEO, Barcode Nanotech Next Generation Therapeutics <\/a><\/td>\n<\/tr>\n
12:15 - 12:30<\/td>Ofer Sharon<\/a>, MD, CEO, OncoHost<\/td>\n<\/tr>\n
12:30 - 12:45<\/td>Avi Veidman, Co-founder and CEO, Nucleai<\/td>\n<\/tr>\n
12:45 - 13:00<\/td>Vered Bar, PhD, VP, R&D, Curesponse <\/a><\/td>\n<\/tr>\n
13:00 - 13:15<\/td>Inbal Zafir-Lavie, PhD, CEO and Co-founder, Gina Life <\/a> <\/td>\n<\/tr>\n
13:15 - 13:30<\/td>Roi Feingersch, PhD, CEO and Founder, FORESEE GENOMICS <\/a> <\/td>\n<\/tr>\n
13:30 - 13:45<\/td>Assaf Halevy, Founder and CEO, 2bPrecise, Genomics and Precision Medicine <\/a> <\/td>\n<\/tr>\n
14:00 - 15:00<\/td>Lunch Break<\/b><\/td>\n<\/tr>\n
<\/td>HALL B<\/b><\/td>\n<\/tr>\n
09:30-14:00<\/td>DIGITAL RECONSTRUCTION OF HEALTHCARE<\/b><\/td>\n<\/tr>\n
11:00 - 11:30<\/td>Coffee Break<\/b><\/td>\n<\/tr>\n
<\/td>Chairperson: Anat Naschitz<\/a>, Founder and CEO, 9xchange; Co-founder, OrbiMed Israel<\/td>\n<\/tr>\n
09:30 - 09:35<\/td>Opening Remarks: Anat Naschitz<\/a>, Founder and CEO, 9xchange; Co-founder, OrbiMed Israel<\/td>\n<\/tr>\n
09:35 - 09:55<\/td>Guy Spigelman, EMEA Lead Healthcare and Life Sciences Startups, Amazon Web Services (AWS), \"How Big Tech and High Performance Computing will Impact Healthcare and Life Sciences\" <\/td>\n<\/tr>\n
09:55 - 10:15<\/td>Elliot Menschik, MD, PhD, CDO, Resilience, \"Software-defined biomanufacturing of therapeutics\" <\/td>\n<\/tr>\n
10:15 - 10:30<\/td>Avinatan Hassidim, Head of Google Israel research group, Google, \"Reimagining the medical record\" <\/td>\n<\/tr>\n
10:30 - 10:45<\/td>Prof. Sam Shah, PhD, Chief Medical Strategy Officer, Numan, \"Digital first: building a full stack health provider inside and outside the NHS\" <\/td>\n<\/tr>\n
10:45 - 11:00<\/td>Dedi Gilad, CEO and Co-founder, TytoCare, \"The state of virtual care industry in the post-COVID era,\" Fireside chat with: Anat Naschitz<\/a>, Founder and CEO, 9xchange; Co-founder, OrbiMed Israel<\/td>\n<\/tr>\n
11:30 - 11:45<\/td>Amnon Bar Lev, Co-founder and CEO, Alike.Health <\/a><\/td>\n<\/tr>\n
11:45 - 12:00<\/td>Kira Radinsky, PhD, Founder, CEO and CTO, Diagnostic Robotics <\/a> <\/td>\n<\/tr>\n
12:00 - 12:15<\/td>Anat Naschitz<\/a>, Founder and CEO, 9xchange,; Co-founder, OrbiMed Israel, \"9xchange, molecule marketplace\" <\/td>\n<\/tr>\n
12:15 - 12:30<\/td>Amir Trabelsi, Co-founder and CEO, Genoox <\/a> <\/td>\n<\/tr>\n
12:30 - 12:45<\/td>Orr Inbar, Co-founder and CEO, QuantHealth <\/a> <\/td>\n<\/tr>\n
12:45 - 13:00<\/td>Israel (Srulik) Dvorsky, Co-founder and CEO, TailorMed <\/a> <\/td>\n<\/tr>\n
13:00 - 13:15<\/td>Itai Gueta, MD, Institue of Clinical Pharmacology, Sheba Tel Ha Shomer Medical Center, \"MDCIone - customer perspective\" <\/td>\n<\/tr>\n
13:15 - 13:30<\/td>Eliran Malki, Co-founder and CEO, Belong.Life<\/td>\n<\/tr>\n
13:30 - 13:45<\/td>Chris Guiffre, CFO and COO, Pear Therapeutics <\/a> \"ZOOM\"<\/td>\n<\/tr>\n
14:00 - 15:00<\/td>Lunch Break<\/td>\n<\/tr>\n
<\/td>HALL C<\/b><\/td>\n<\/tr>\n
09:30 - 14:00<\/td>INFECTIOUS DISEASES - BREAKING BARRIERS IN VACCINE DEVELOPMENT, THERAPY AND DIAGNOSIS MODALITIES<\/b><\/td>\n<\/tr>\n
11:00 - 11:30<\/td>Coffee Break<\/b><\/td>\n<\/tr>\n
<\/td>Chairperson: Prof. Dror Mevorach, MD, Head of Internal Medicine, Hadassah Hospital<\/td>\n<\/tr>\n
09:35 - 09:55<\/td>Prof. Dror Mevorach, MD, Head of Internal Medicine, Hadassah Hospital, \"Covid19, where are we going?\"<\/td>\n<\/tr>\n
10:00 - 10:20<\/td>BARRY GREENE<\/a>, CEO, Sage Therapeutics, USA, \"COVID exacerbating mental health issues,\" <\/td>\n<\/tr>\n
10:20 - 10:40<\/td>Prof. Jacob Strahilevitz, MD, Head of the department of Infectious Diseases and Clinical Microbiology, Hadassah Medical Center, \"Antimicrobial stewardship: A societal need to combat resistance\" <\/td>\n<\/tr>\n
10:40 - 11:00<\/td>Prof. Ronen Ben Ami, MD, Head of the Infectious Diseases Unit, Tel Aviv Medical Center, \"Emerging Fungal Threats in 2022\" <\/td>\n<\/tr>\n
11:30 - 11:45<\/td>Nadav Ben-Dov, PhD, CEO and Co-founder, phenofAST <\/a> <\/td>\n<\/tr>\n
11:45 - 12:00<\/td>Eynat Finkelshtein, PhD, CSO, Code Pharma <\/a><\/td>\n<\/tr>\n
12:00 - 12:15<\/td>Moshik Cohen-Kutner, PhD, CEO, Omnix Medical <\/a><\/td>\n<\/tr>\n
12:15 - 12:30<\/td>Jonathan Solomon, CEO and Board Member, Biomx <\/a> <\/td>\n<\/tr>\n
12:30 - 12:45<\/td>Nadav Kidron, CEO and Chairman of the Board, Oravax Medical <\/a> <\/td>\n<\/tr>\n
12:45 - 13:00<\/td>Einat Galamidi Cohen, MD, VP Medical, Enlivex Therapeutics<\/td>\n<\/tr>\n
13:00 - 13:15<\/td>Ofer Chen, MD, VP Clinical Development, Clew Medical <\/a><\/td>\n<\/tr>\n
13:15 - 13:30<\/td>Yotam Levin, MD, CEO, NanoPass <\/a><\/td>\n<\/tr>\n
13:30 - 13:45<\/td>Eddie Sadan, Co-founder, Terrapeutics <\/a><\/td>\n<\/tr>\n
13:45 - 14:00<\/td>Tamar Ben-Yedida, PhD, CSO, BiondVax Pharmaceuticals <\/a><\/td>\n<\/tr>\n
14:00 - 15:00<\/td>Lunch Break<\/b><\/td>\n<\/tr>\n
<\/td>PLENARY SESSION<\/b><\/td>\n<\/tr>\n
15:15 - 15:45<\/td>Alban de la Sabliere, SVP, Head of Sanofi Partnering Sanofi, France, \"Sanofi: Implementing a Play to a Win Strategy\" <\/td>\n<\/tr>\n
15:45 - 16:15<\/td>Ehud Rivlin, PhD, Israel Site Lead Verily, Israel<\/td>\n<\/tr>\n
16:15 - 16:45<\/td>Tal Zaks, MD, PhD, Venture Partner, Orbimed, USA, \"ZOOM\"<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

Biomed Israel 2022 PROGRAM<\/p>\n","protected":false},"author":1,"featured_media":21967,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"acf":[],"yoast_head":"\nProgram Overview - Biomed Israel 2022 Conference and Exhibition<\/title>\n<meta name=\"description\" content=\"View the preliminary program. Reflecting on advancements & evolution of technologies that impact the life sciences enterprise of the future!\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/kenes-exhibitions.com\/biomed2022\/program-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Program Overview - Biomed Israel 2022 Conference and Exhibition\" \/>\n<meta property=\"og:description\" content=\"View the preliminary program. Reflecting on advancements & evolution of technologies that impact the life sciences enterprise of the future!\" \/>\n<meta property=\"og:url\" content=\"https:\/\/kenes-exhibitions.com\/biomed2022\/program-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Biomed 2022\" \/>\n<meta property=\"article:modified_time\" content=\"2022-04-24T11:42:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/kenes-exhibitions.com\/biomed2022\/wp-content\/uploads\/Depositphotos_5351619_L.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2000\" \/>\n\t<meta property=\"og:image:height\" content=\"1318\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebSite\",\"@id\":\"https:\/\/kenes-exhibitions.com\/biomed2022\/#website\",\"url\":\"https:\/\/kenes-exhibitions.com\/biomed2022\/\",\"name\":\"Biomed 2022\",\"description\":\"Biomed 2022 is the largest convention in Israel for Life Sciences and Technology\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/kenes-exhibitions.com\/biomed2022\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/kenes-exhibitions.com\/biomed2022\/program-2\/#primaryimage\",\"url\":\"https:\/\/kenes-exhibitions.com\/biomed2022\/wp-content\/uploads\/Depositphotos_5351619_L.jpg\",\"contentUrl\":\"https:\/\/kenes-exhibitions.com\/biomed2022\/wp-content\/uploads\/Depositphotos_5351619_L.jpg\",\"width\":2000,\"height\":1318,\"caption\":\"woman hand pressing social media icon\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/kenes-exhibitions.com\/biomed2022\/program-2\/#webpage\",\"url\":\"https:\/\/kenes-exhibitions.com\/biomed2022\/program-2\/\",\"name\":\"Program Overview - Biomed Israel 2022 Conference and Exhibition\",\"isPartOf\":{\"@id\":\"https:\/\/kenes-exhibitions.com\/biomed2022\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/kenes-exhibitions.com\/biomed2022\/program-2\/#primaryimage\"},\"datePublished\":\"2016-05-15T07:26:38+00:00\",\"dateModified\":\"2022-04-24T11:42:11+00:00\",\"description\":\"View the preliminary program. Reflecting on advancements & evolution of technologies that impact the life sciences enterprise of the future!\",\"breadcrumb\":{\"@id\":\"https:\/\/kenes-exhibitions.com\/biomed2022\/program-2\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/kenes-exhibitions.com\/biomed2022\/program-2\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/kenes-exhibitions.com\/biomed2022\/program-2\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/kenes-exhibitions.com\/biomed2022\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Biomed Israel 2022 Agenda\"}]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Program Overview - Biomed Israel 2022 Conference and Exhibition","description":"View the preliminary program. Reflecting on advancements & evolution of technologies that impact the life sciences enterprise of the future!","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/kenes-exhibitions.com\/biomed2022\/program-2\/","og_locale":"en_US","og_type":"article","og_title":"Program Overview - Biomed Israel 2022 Conference and Exhibition","og_description":"View the preliminary program. Reflecting on advancements & evolution of technologies that impact the life sciences enterprise of the future!","og_url":"https:\/\/kenes-exhibitions.com\/biomed2022\/program-2\/","og_site_name":"Biomed 2022","article_modified_time":"2022-04-24T11:42:11+00:00","og_image":[{"width":2000,"height":1318,"url":"https:\/\/kenes-exhibitions.com\/biomed2022\/wp-content\/uploads\/Depositphotos_5351619_L.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebSite","@id":"https:\/\/kenes-exhibitions.com\/biomed2022\/#website","url":"https:\/\/kenes-exhibitions.com\/biomed2022\/","name":"Biomed 2022","description":"Biomed 2022 is the largest convention in Israel for Life Sciences and Technology","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/kenes-exhibitions.com\/biomed2022\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/kenes-exhibitions.com\/biomed2022\/program-2\/#primaryimage","url":"https:\/\/kenes-exhibitions.com\/biomed2022\/wp-content\/uploads\/Depositphotos_5351619_L.jpg","contentUrl":"https:\/\/kenes-exhibitions.com\/biomed2022\/wp-content\/uploads\/Depositphotos_5351619_L.jpg","width":2000,"height":1318,"caption":"woman hand pressing social media icon"},{"@type":"WebPage","@id":"https:\/\/kenes-exhibitions.com\/biomed2022\/program-2\/#webpage","url":"https:\/\/kenes-exhibitions.com\/biomed2022\/program-2\/","name":"Program Overview - Biomed Israel 2022 Conference and Exhibition","isPartOf":{"@id":"https:\/\/kenes-exhibitions.com\/biomed2022\/#website"},"primaryImageOfPage":{"@id":"https:\/\/kenes-exhibitions.com\/biomed2022\/program-2\/#primaryimage"},"datePublished":"2016-05-15T07:26:38+00:00","dateModified":"2022-04-24T11:42:11+00:00","description":"View the preliminary program. Reflecting on advancements & evolution of technologies that impact the life sciences enterprise of the future!","breadcrumb":{"@id":"https:\/\/kenes-exhibitions.com\/biomed2022\/program-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/kenes-exhibitions.com\/biomed2022\/program-2\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/kenes-exhibitions.com\/biomed2022\/program-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/kenes-exhibitions.com\/biomed2022\/"},{"@type":"ListItem","position":2,"name":"Biomed Israel 2022 Agenda"}]}]}},"_links":{"self":[{"href":"https:\/\/kenes-exhibitions.com\/biomed2022\/wp-json\/wp\/v2\/pages\/2443"}],"collection":[{"href":"https:\/\/kenes-exhibitions.com\/biomed2022\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/kenes-exhibitions.com\/biomed2022\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/kenes-exhibitions.com\/biomed2022\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/kenes-exhibitions.com\/biomed2022\/wp-json\/wp\/v2\/comments?post=2443"}],"version-history":[{"count":476,"href":"https:\/\/kenes-exhibitions.com\/biomed2022\/wp-json\/wp\/v2\/pages\/2443\/revisions"}],"predecessor-version":[{"id":24071,"href":"https:\/\/kenes-exhibitions.com\/biomed2022\/wp-json\/wp\/v2\/pages\/2443\/revisions\/24071"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/kenes-exhibitions.com\/biomed2022\/wp-json\/wp\/v2\/media\/21967"}],"wp:attachment":[{"href":"https:\/\/kenes-exhibitions.com\/biomed2022\/wp-json\/wp\/v2\/media?parent=2443"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}